Back to Search
JONATHAN SCHILLER, MD
MD
Pediatric Orthopaedic Surgery Physician
NPI: 1790808020IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery — Pediatric Orthopaedic Surgery
Code: 207XP3100X
12636(RI)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
HAHNEMANN UNIVERSITY COLLEGE OF MEDICINE
Class of 2002
Research & Publications (20)
Brace management in adolescent idiopathic scoliosis.
PMID 19484317·Clin Orthop Relat Res·2010
6-review
Foot and ankle fellowship training: a national survey of past, present, and prospective fellows.
PMID 18275734·Foot Ankle Int·2008
8-other
Increased lengthening rate decreases expression of fibroblast growth factor 2, platelet-derived growth factor, vascular endothelial growth factor, and CD31 in a rat model of distraction osteogenesis.
PMID 18209624·J Pediatr Orthop·2007
7-preclinical
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
PMID 19238328·Invest New Drugs·2010
3-trial
Evaluation of carbon tetrachloride-induced stress on rat hepatocytes by 31P NMR and MALDI-TOF mass spectrometry: lysophosphatidylcholine generation from unsaturated phosphatidylcholines.
PMID 19428359·Chem Phys Lipids·2009
7-preclinical
Synaptic integration in tuft dendrites of layer 5 pyramidal neurons: a new unifying principle.
PMID 19661433·Science·2009
7-preclinical
Role, metabolism, chemical modifications and applications of hyaluronan.
PMID 19442142·Curr Med Chem·2009
6-review
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.
PMID 19224857·J Clin Oncol·2009
3-trial
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
PMID 19467474·Lancet Infect Dis·2009
6-review
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
Application of flavonoids - quercetin and rutin - as new matrices for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of Pt(II) and Pd(II) complexes.
PMID 19350526·Rapid Commun Mass Spectrom·2009
8-other
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study.
PMID 19347984·J Thorac Oncol·2009
3-trial
Lysophospholipids: their generation, physiological role and detection. Are they important disease markers?
PMID 19275729·Mini Rev Med Chem·2009
6-review
Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect.
PMID 19294383·Cancer Immunol Immunother·2009
7-preclinical
Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be better after all.
PMID 19470911·J Clin Oncol·2009
8-other
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
PMID 19470949·J Natl Cancer Inst·2009
4-observational
Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
PMID 19597027·J Clin Oncol·2009
3-trial
Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials.
PMID 19519255·J Infect Dis·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2 DUDLEY ST
PROVIDENCE, RI 02905 - Phone
- (401) 457-2106
Quick Facts
- NPI
- 1790808020
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile